echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature's New Breakthrough: First Confirmation of the Origin of a Deadly Brain Tumor!

    Nature's New Breakthrough: First Confirmation of the Origin of a Deadly Brain Tumor!

    • Last Update: 2022-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
       

       

    Image: From left to right: Dr.
    Paul Northcott, Dr.
    Kyle Smith, Dr.
    Brian Gudenas, and Dr.

    Laure Biannic.

    Image source: St.
    Judas Children's Research Hospital

    Scientists at St.
    Judah's Children's Research Hospital have discovered which cells produce certain high-risk medulloblastoma populations
    .
    These findings will help researchers better understand the biology of the disease, as well as develop better research models and guide them in their search for therapeutic targets
    .
    The findings are published today in the
    journal Nature.

    Medulloblastoma is the most common malignant brain tumor
    in children.
    It has four molecular subgroups: SHH, WNT, Group 3 (Group 3) and Group 4 (Group 4
    ).
    Studies have revealed which neural tissues produce SHH and WNT: SHH comes from the outer particle layer (where granular neurons grow), and WNT comes from the brainstem
    .
    However, the origin of groups 3 and 4 medulloblastoma is difficult to determine
    .

    Now, scientists have traced the developmental starting point of groups 3 and 4 of medulloblastoma, the rhombic lip, a structure
    for early development of the cerebellum.
    This is the first time researchers have identified the specific origin of group 3 medulloblastomas and reinforced previous discoveries
    about group 4 medulloblastomas.

    Dr Paul Northcott, corresponding author of the Department of Developmental Neurobiology in St.
    Judas, said: "There is ambiguity and overlap between groups 3 and 4, which makes it challenging
    to determine their origins.
    " "We already have evidence that these groups have some sort of common ancestry and then possibly differentiate based on the genetic events that drive these tumors, but until now we haven't been able to definitively identify
    .
    "

    "After helping to discover and describe Groups 3 and 4 more than a decade ago, my lab has been curious
    to solve their developmental biology problems and figure out if they share a common ancestor.
    "

    Find the right map

    In 2019, Northcott and his team released an atlas
    of mouse cerebellar development.
    The work relied on single-cell transcriptional profiling, allowing the researchers to compare the profiles
    of medulloblastoma patients and mouse cerebellums.
    Previous mouse atlas studies have shown that group 4 medulloblastomas originate from unipolar brush cells and can also be traced back to the developmental process
    of the rhombus lips.
    But the origin of group 3 medulloblastomas remains unclear
    .

    Northcott then collaborated with Dr.
    Kathleen Millen of Seattle Children's Hospital on the study
    .
    Millen and her team created the first atlas
    of human cerebellar development.
    With the human genome map, Northcott and his team were able to look for transcriptome signatures
    of different medulloblastoma subsets in the context of the same species.
    Notably, the scientists found that both groups 3 and 4 may have come from rhomboid lips, one of the main regions of
    the developing cerebellum.

    "Once we have the human map, everything is turned on, and there are these obvious differences between human and mouse cerebellar development, which suggests that human development is much more
    complex.
    "

    There was a cancerous detour on the road to development

    Think of the rhombus lips as the starting line
    of a race.
    Stem cells and progenitor cells are aggregating, ready to take off
    .
    Once the cells begin their journey, they begin to differentiate, differentiating into different groups
    of cells in different directions.

    The researchers matched
    these different cell populations from the rhomboid lips to groups 3 and 4 medulloblastomas.
    Group 3 cells are more primitive (they are closer to the starting line), while Group 4 cells develop farther (they go farther at the starting line
    ).

    The findings answer why groups 3 and 4 have some of the same characteristics, but are different
    .
    They arise in the same region, but come from different cell populations
    on the trajectory of their development.

    The findings also highlight the need to combine expertise from different disciplines for collaborative research
    .
    For example, in addition to transcriptomics analysis, the researchers also used imaging techniques to help with their research
    .
    Northcott and his team collaborated on this work with the late Dr.
    Zoltán Patay, who at the time served as chair of the Department of
    Diagnostic Imaging at St.
    Judas.

    Patay, one of the paper's authors, spoke of the study: "This work highlights the need and value
    of dialogue and exchange of ideas between basic research scientists and clinical experts, including radiologists in research work.
    This collaboration enables observational MRI results and basic research data to be synergistically validated with each other to determine the anatomical starting point
    for these tumors in groups 3 and 4 of medulloblastoma.
    This is a possibility
    unique to St.
    Judas.

    In addition to answering an urgent biological question, these findings may help researchers design better models to study these subpopulations
    .
    Understanding cell origin will also allow researchers to compare blast cells and tumor cells for a more nuanced understanding of tumor-specific dependencies that can be explored
    therapeutically.

    essay

    Rhombic lip implicated in origins of high-risk medulloblastoma


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.